Hypothesizing that hexanoic acid indirectly enhances the anti‐tumor activity of CD8+ T cells through immune cells with immunosuppressive activity, we evaluated its effects on TAMs, MDSCs, and Tregs in vivo. The gene discussed is CD8A; the disease is neoplasm.